Nivolumab and Pembrolizumab experience in the second line therapy of your NSCLC patients - 102038

Spotlight
Video

Nivolumab and Pembrolizumab experience in the second line therapy of your NSCLC patients

Loading........
Description: Nathan Pennell, MD of Cleveland Clinic discusses his experience with Nivolumab and Pembrolizumab in the second line therapy of your NSCLC patients
Shared By : AnnualMeeting2016
Posted on : 06/24/16
Added : 2 years ago



Recommended

Nothing found.

More From AnnualMeeting2016

Nothing found.